Corcept Therapeutics Stock Forecast

Buy or Hold candidate since Apr 24, 2026 Gain 73.49%

The Corcept Therapeutics Incorporated stock price fell by -2.25% on the last day (Thursday, 18th Jun 2026) from $81.75 to $79.91. During the last trading day the stock fluctuated 4.91% from a day low at $79.40 to a day high of $83.30. The price has risen in 6 of the last 10 days and is up by 6.7% over the past 2 weeks. Volume has increased on the last day by 876 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $137.92 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 129.39% during the next 3 months and, with a 90% probability hold a price between $162.87 and $195.52 at the end of this 3-month period.

CORT Signals & Forecast

The Corcept Therapeutics Incorporated stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $81.82. On a fall, the stock will find some support from the long-term average at approximately $64.94. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 16, 2026, and so far it has fallen -4.54%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The stock had a Golden Star Signal on Tuesday, August 05, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Corcept Therapeutics Incorporated stock

Corcept Therapeutics Incorporated finds support from accumulated volume at $78.12 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.90 between high and low, or 4.91%. For the last week, the stock has had daily average volatility of 4.12%.

Our recommended stop-loss: $76.56 (-4.19%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (CORT) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Corcept Therapeutics Incorporated to open at $80.87, and during the day (based on 14 day Average True Range), to move between $78.27 and $81.55, which gives a possible trading interval of +/-$3.27 (+/-4.18%) up or down from last closing price. If Corcept Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 4.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $78.12 (2.24%) than the resistance at $81.75 (2.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Corcept Therapeutics Incorporated stock A Buy?

Corcept Therapeutics Incorporated holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.806 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $80.87 ( 1.20%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk